Literature DB >> 2220821

More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians.

P Hechtman1, F Kaplan, J Bayleran, B Boulay, E Andermann, M de Braekeleer, S Melançon, M Lambert, M Potier, R Gagné.   

Abstract

Two Tay-Sachs disease (TSD) patients of French-Canadian origin were shown by Myerowitz and Hogikyan to be homozygous for a 7.6-kb deletion mutation at the 5' end of the hexosaminidase A alpha-subunit gene. In order to determine whether all French-Canadian TSD patients were homozygotes for the deletion allele and to assess the geographic origins of TSD in this population, we ascertained 12 TSD families of French-Canadian origin and screened for occurrence of mutations associated with infantile TSD. DNA samples were obtained from 12 French-Canadian TSD families. Samples were analyzed using polymerase-chain-reaction (PCR) amplification followed by hybridization to allele-specific oligonucleotides (ASO) or by restriction analysis of PCR products. In some cases Southern analysis of genomic DNA was performed. Eighteen of the 22 independently segregating mutant chromosomes in this sample carried the 7.6-kb deletion mutation at the 5' end of the gene. One chromosome carried the 4-nucleotide insertion in exon 11 (a "Jewish" mutation). In this population no individuals were detected who had the substitution at the splice junction of exon 12 previously identified in Ashkenazi Jews. One chromosome carried an undescribed B1 mutation; this allele came from a parent of non-French-Canadian origin. Patients in three families carried TSD alleles different from any of the above mutations. The 5' deletion mutation clusters in persons originating in southeastern Quebec (Gaspé) and adjacent counties of northern New Brunswick.

Entities:  

Mesh:

Year:  1990        PMID: 2220821      PMCID: PMC1683681     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  Synthesis of beta-hexosaminidase in cell-free translation and in intact fibroblasts: an insoluble precursor alpha chain in a rare form of Tay-Sachs disease.

Authors:  R L Proia; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

2.  Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.

Authors:  J Bayleran; P Hechtman; W Saray
Journal:  Clin Chim Acta       Date:  1984-11-15       Impact factor: 3.786

3.  Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component.

Authors:  S Okada; J S O'Brien
Journal:  Science       Date:  1969-08-15       Impact factor: 47.728

4.  A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts.

Authors:  P Hechtman; K Khoo; C Isaacs
Journal:  Clin Genet       Date:  1983-09       Impact factor: 4.438

5.  Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A.

Authors:  H J Kytzia; K Sandhoff
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

6.  A shortened beta-hexosaminidase alpha-chain in an Italian patient with infantile Tay-Sachs disease.

Authors:  G Zokaeem; J Bayleran; P Kaplan; P Hechtman; E F Neufeld
Journal:  Am J Hum Genet       Date:  1987-06       Impact factor: 11.025

7.  Organization of the gene encoding the human beta-hexosaminidase alpha-chain.

Authors:  R L Proia; E Soravia
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

8.  Genetic variants of Tay-Sachs disease: Tay-Sachs disease and Sandhoff's disease in French Canadians, juvenile Tay-Sachs disease in Lebanese Canadians, and a Tay-Sachs screening program in the French-Canadian population.

Authors:  E Andermann; C R Scriver; L S Wolfe; L Dansky; F Andermann
Journal:  Prog Clin Biol Res       Date:  1977

9.  Recurrent mutation, gene conversion, or recombination at the human phenylalanine hydroxylase locus: evidence in French-Canadians and a catalog of mutations.

Authors:  S W John; R Rozen; C R Scriver; R Laframboise; C Laberge
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

10.  Different mutations in Ashkenazi Jewish and non-Jewish French Canadians with Tay-Sachs disease.

Authors:  R Myerowitz; N D Hogikyan
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

View more
  11 in total

1.  The French Canadian Tay-Sachs disease deletion mutation: identification of probable founders.

Authors:  M De Braekeleer; P Hechtman; E Andermann; F Kaplan
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

2.  Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.

Authors:  B R Akerman; M R Natowicz; M M Kaback; M Loyer; E Campeau; R A Gravel
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

3.  Heterozygosity for Tay-Sachs disease in non-Jewish Americans with ancestry from Ireland or Great Britain.

Authors:  M van Bael; M R Natowicz; J Tomczak; E E Grebner; E M Prence
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

4.  Beta-hexosaminidase splice site mutation has a high frequency among non-Jewish Tay-Sachs disease carriers from the British Isles.

Authors:  E C Landels; P M Green; I H Ellis; A H Fensom; M Bobrow
Journal:  J Med Genet       Date:  1992-08       Impact factor: 6.318

5.  Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England.

Authors:  B Triggs-Raine; M Richard; N Wasel; E M Prence; M R Natowicz
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

6.  Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.

Authors:  D Phaneuf; M Lambert; R Laframboise; G Mitchell; F Lettre; R M Tanguay
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

7.  Multiple mutations are responsible for the high frequency of metachromatic leukodystrophy in a small geographic area.

Authors:  U Heinisch; J Zlotogora; S Kafert; V Gieselmann
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

8.  The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada.

Authors:  P Hechtman; B Boulay; M De Braekeleer; E Andermann; S Melançon; J Larochelle; C Prevost; F Kaplan
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

9.  A third mutation at the CpG dinucleotide of codon 504 and a silent mutation at codon 506 of the HEX A gene.

Authors:  B H Paw; L C Wood; E F Neufeld
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

10.  Allele-specific amplification of genomic DNA for detection of deletion mutations: identification of a French-Canadian Tay-Sachs mutation.

Authors:  F Kaplan; B Boulay; J Bayleran; P Hechtman
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.